Eu Agency Recommends Authorizing Use Of Pfizer Vaccine

The European Medicines Agency (EMA) Monday recommended granting marketing authorization for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent COVID-19 in people from 16 years of age.

EMA’s scientific opinion paves the way for the first marketing authorization of a COVID-19 vaccine in the EU by the European Commission, with all the safeguards, controls and obligations this entails, said the Amsterdam-based EMA in a press release.

EMA’s human medicines committee has completed its rigorous evaluation of Comirnaty, concluding by consensus that sufficiently robust data on the quality, safety and efficacy of the vaccine are now available to recommend a formal conditional marketing authorisation.

“Today’s positive news is an important step forward in our fight against this pandemic, which has caused suffering and hardship for so many,” said Emer Cooke, Executive Director of EMA. “Our thorough evaluation means that we can confidently assure EU citizens of the safety and efficacy of this vaccine and that it meets necessary quality standards,” added Cooke.

 

SOURCE : TIMES KUWAIT

Comments Post Comment

Leave a Comment

Submit